A new role for hypoxia in tumor progression: induction of fragile site triggering genomic rearrangements and formation of complex DMs and HSRs - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Molecular Cell Année : 1998

A new role for hypoxia in tumor progression: induction of fragile site triggering genomic rearrangements and formation of complex DMs and HSRs

Arnaud Coquelle
  • Fonction : Auteur
  • PersonId : 864555
Franck Toledo
  • Fonction : Auteur
  • PersonId : 980869
Anne Bieth
  • Fonction : Auteur
Michelle Debatisse
Connectez-vous pour contacter l'auteur

Résumé

Genome rearrangements including gene amplification are frequent properties of tumor cells, but how they are related to the tumor microenvironment is unknown. Here, we report direct evidence for a causal relationship between hypoxia, induction of fragile sites, and gene amplification. Recently, we showed that breaks at fragile sites initiate intrachromosomal amplification. We demonstrate here that hypoxia is a potent fragile site inducer and that, like fragile sites inducing drugs, it drives fusion of double minutes (DMs) and their targeted reintegration into chromosomal fragile sites, generating homogeneously staining regions (HSRs). This pathway operates efficiently for DMs bearing different sequences, suggesting a model of hypoxia-driven formation of the HSRs containing nonsyntenic sequences frequently observed in solid tumors.

Dates et versions

inserm-03199013 , version 1 (15-04-2021)

Identifiants

Citer

Arnaud Coquelle, Franck Toledo, Sabine Stern, Anne Bieth, Michelle Debatisse. A new role for hypoxia in tumor progression: induction of fragile site triggering genomic rearrangements and formation of complex DMs and HSRs. Molecular Cell, 1998, 2 (2), pp.259-265. ⟨10.1016/s1097-2765(00)80137-9⟩. ⟨inserm-03199013⟩
117 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More